SAT-230 Biomarker-based profiling of pathomechanisms across distinct clinical stages of cirrhosis
Vlad Țâru(Iuliu Hațieganu University of Medicine and Pharmacy), Benedikt Simbrunner(Austrian Academy of Sciences), Michael Schwarz(Medical University of Vienna), Peng Sun(Biogen (United States)), Stefan Günther Kauschke, Nina Dominik(Medical University of Vienna), Paul Thöne(Medical University of Vienna), Lukas Hartl(Medical University of Vienna), Philipp Schwabl(Austrian Academy of Sciences), Tammo Lambert Tergast(Medizinische Hochschule Hannover), Michael Trauner(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Mathias Jachs(Medical University of Vienna), Barbara Kistler(Boehringer Ingelheim (Germany)), Christian Sebesta(Donauspital), Lorenz Balcar(Medical University of Vienna), Georg Kramer(Medical University of Vienna), Katharina Regnat(Medical University of Vienna), Kerstin Zinober(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna)
Cited by 0
Related Papers
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
|Nature Protocols|2015|119